These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11027491)

  • 1. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.
    Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG
    Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
    Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO
    J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J; Lintner F; Jellinger KA
    Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
    Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
    Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations.
    Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE
    Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
    Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
    Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
    J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.
    Prior R; D'Urso D; Frank R; Prikulis I; Cleven S; Ihl R; Pavlakovic G
    Am J Pathol; 1996 Jun; 148(6):1749-56. PubMed ID: 8669461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-β using NMR spectroscopy.
    Sun N; Hartmann R; Lecher J; Stoldt M; Funke SA; Gremer L; Ludwig HH; Demuth HU; Kleinschmidt M; Willbold D
    J Pept Sci; 2012 Nov; 18(11):691-5. PubMed ID: 23001756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Abeta terminal end-specific antibodies and sensitive ELISA for Abeta variant.
    Horikoshi Y; Sakaguchi G; Becker AG; Gray AJ; Duff K; Aisen PS; Yamaguchi H; Maeda M; Kinoshita N; Matsuoka Y
    Biochem Biophys Res Commun; 2004 Jul; 319(3):733-7. PubMed ID: 15184044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template.
    Ha C; Ryu J; Park CB
    Biochemistry; 2007 May; 46(20):6118-25. PubMed ID: 17455909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.